Despite ERBB3 expression in basal-like/triple-negative breast cancer appearing to be low, our study suggests that the NRG1β/ERBB3/ERBB2 axis in basal-like/triple-negative breast cancer patients may support tumor cell dissemination by promoting anchorage-independent cell growth. Here, ERBB2 is linked to triple-negative breast carcinoma.